AI Article Synopsis

  • A significant percentage (3% to 28%) of individuals infected with the chikungunya virus (CHIKV) show no symptoms, highlighting the need for better screening methods beyond traditional diagnostic tests like ELISAs.* -
  • This study developed two new monoclonal antibodies targeting CHIKV's E1 protein and utilized them in a fluorescence-linked immunosorbent assay (FLISA), which proved to be more effective than ELISA in detecting the virus.* -
  • FLISA demonstrated a lower limit of detection, allowing it to identify CHIKV more accurately in human samples, outperforming ELISA, especially in the presence of human sera and blood.*

Article Abstract

Background: When infected with the chikungunya virus (CHIKV), 3% to 28% of CHIKV-infected individuals remain asymptomatic, necessitating the development of improved high-throughput screening methods to overcome the limitations of molecular diagnostics or enzyme-linked immunosorbent assays (ELISAs).

Objective: In this study, two novel monoclonal antibodies (mAbs) targeting envelope 1 (E1) of CHIKV were developed and applied in a fluorescence-linked immunosorbent assay (FLISA) using coumarin-derived dendrimer as the fluorophore.

Methods: The performance of the FLISA was compared with that of ELISA.

Results: Using the two novel mAbs (2B5 and 2C8), FLISA could detect 1 × 105 PFU/mL of CHIKV, exhibiting a 2-fold lower limit of detection (LOD) compared to ELISA. The LOD of FICT corresponded to a comparative threshold value of 23.95 and 4  ×  106 of RNA copy number/µL. In the presence of human sera and blood, virus detection by FLISA was 3-fold better than ELISA, with an LOD of 2 × 105 PFU/mL. Sera and blood interfered with the ELISA, resulting in 6 × 105 PFU/mL as the LOD.

Conclusions: FLISA using two novel mAbs and coumarin-derived dendrimer is a superior diagnostic assay for detecting CHIKV in human sera and blood, compared to conventional ELISA.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000502823DOI Listing

Publication Analysis

Top Keywords

105 pfu/ml
12
sera blood
12
immunosorbent assay
8
chikungunya virus
8
virus detection
8
coumarin-derived dendrimer
8
novel mabs
8
elisa lod
8
human sera
8
flisa
5

Similar Publications

Optimization of the large-scale production for Erwinia amylovora bacteriophages.

Microb Cell Fact

December 2024

Laboratory of Aquatic Biomedicine, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, 08826, Republic of Korea.

Background: Fire blight, caused by Erwinia amylovora, poses a significant threat to global agriculture, with antibiotic-resistant strains necessitating alternative solutions such as phage therapy. Scaling phage therapy to an industrial level requires efficient mass-production methods, particularly in optimizing the seed culture process. In this study, we investigated large-scale E.

View Article and Find Full Text PDF

Background: The darkling beetle Zophobas morio can be implemented as an alternative in vivo model to study different intestinal colonization aspects. Recently, we showed that its larvae can be colonized by multidrug-resistant Escherichia coli strains administered via contaminated food (for 7 d) for a total experimental duration of 28 d.

Method: In the present work, we aimed to shorten the model to 14 d (T14) by administering the previously used CTX-M-15 extended-spectrum β-lactamase-producing ST131 E.

View Article and Find Full Text PDF

Biofilm Prevention and Removal in Non-Target Strain by -like Coliphage.

Biomedicines

October 2024

Grup de Biotecnologia Molecular i Industrial, Departament d'Enginyeria Química, Universitat Politècnica de Catalunya (UPC-BarcelonaTech), Rambla de Sant Nebridi 22, 08222 Terrassa, Spain.

Bacteriophages have gained significant interest as a potential solution to combat harmful bacteria, especially in the fight against antimicrobial resistance. With the rise in drug-resistant microorganisms, the medical community is increasingly exploring new alternatives to traditional antibiotics, and bacteriophages offer several advantages in this regard. However, phage applications still face some challenges, such as host specificity.

View Article and Find Full Text PDF

Salivary detection of Chikungunya virus infection using a portable and sustainable biophotonic platform coupled with artificial intelligence algorithms.

Sci Rep

September 2024

Innovation Center in Salivary Diagnostic and Nanobiotechnology, Department of Physiology, Institute of Biomedical Sciences, Federal University of Uberlandia, ARFIS, Av. Pará, 1720, Campus Umuarama, Uberlândia, Minas Gerais, CEP 38400-902, Brazil.

The current detection method for Chikungunya Virus (CHIKV) involves an invasive and costly molecular biology procedure as the gold standard diagnostic method. Consequently, the search for a non-invasive, more cost-effective, reagent-free, and sustainable method for the detection of CHIKV infection is imperative for public health. The portable Fourier-transform infrared coupled with Attenuated Total Reflection (ATR-FTIR) platform was applied to discriminate systemic diseases using saliva, however, the salivary diagnostic application in viral diseases is less explored.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!